BioMaxima S.A. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was PLN 11.67 million compared to PLN 13.05 million a year ago. Net loss was PLN 0.366 million compared to net income of PLN 0.933 million a year ago. Basic loss per share from continuing operations was PLN 0.09 compared to basic earnings per share from continuing operations of PLN 0.22 a year ago. Diluted loss per share from continuing operations was PLN 0.09 compared to diluted earnings per share from continuing operations of PLN 0.21 a year ago.
For the nine months, sales was PLN 33.44 million compared to PLN 130.52 million a year ago. Net income was PLN 0.493 million compared to PLN 28.57 million a year ago. Basic earnings per share from continuing operations was PLN 0.11 compared to PLN 6.6 a year ago. Diluted earnings per share from continuing operations was PLN 0.11 compared to PLN 6.41 a year ago.